Endocannabinoid response in acute ischemic stroke: elevated 2-arachidonoylglycerol
View ORCID ProfileMarina Buciuc, Gian Marco Conte, View ORCID ProfileEugene L. Scharf
doi: https://doi.org/10.1101/2020.10.29.20222646
Marina Buciuc
aDepartments of Neurology, Mayo Clinic, Rochester, MN, USA
Gian Marco Conte
bDepartments of Neurology Radiology, Mayo Clinic, Rochester, MN, USA
Eugene L. Scharf
aDepartments of Neurology, Mayo Clinic, Rochester, MN, USA
Data Availability
Anonymized data are available from the corresponding author upon request from any qualified investigator for purposes of replicating procedures and results.
Posted November 03, 2020.
Endocannabinoid response in acute ischemic stroke: elevated 2-arachidonoylglycerol
Marina Buciuc, Gian Marco Conte, Eugene L. Scharf
medRxiv 2020.10.29.20222646; doi: https://doi.org/10.1101/2020.10.29.20222646
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)